Aldosterone synthesis inhibitors and epoxide hydrolase inhibitors, which target two enzymes downstream from the renin-angiotensin pathway, are also in the pharmaceutical industry's pipeline.

The aldosterone-renin ratio (ARR) has gained popularity as a screening test for primary hyperaldosteronism, a probably underdiagnosed cause of hypertension. However, studies have yielded varying ...

The validity as well as the usefulness of measuring components of the renin-angiotensin-aldosterone system in the diagnosis and treatment of patients with elevated blood pressure (BP) has been ...

Chronic heart failure is a syndrome, not a specific disease, and occurs as a final common pathway in multiple ... and activation of the renin-angiotensin-aldosterone system (RAAS).